HOME › DRUGS › SASANLIMAB
ACTIVE SUBSTANCE / INN

SASANLIMAB

Brand name(s): Zumrad
EMA LISTED
APPLICATION WITHDRAWN
Urinary Bladder Neoplasms
ACTIVE SUBSTANCE
Sasanlimab
REGULATORS
EMA
SPONSORS / MAH
Pfizer Europe MA EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ZumradPfizer Europe MA EEIGApplication withdrawnUrinary Bladder Neoplasms

FULL INTELLIGENCE ON SASANLIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →